Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sultan Qaboos Univ Med J ; 22(1): 129-133, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35299806

ABSTRACT

Measles is a highly contagious infectious disease. Despite aggressive national initiatives to eradicate measles, outbreaks have occurred in recent years. We report three infants who presented to a tertiary care hospital in Muscat, Oman, in 2019 with measles and then developed pneumonitis, received intensive care treatment and made full recoveries. Infants can have an atypical presentation and develop severe symptoms. Pneumonitis is a serious complication and the management strategies are controversial. The early detection of measles and isolation of affected individuals play major roles in the elimination of measles outbreaks.


Subject(s)
Measles , Pneumonia , Disease Outbreaks , Hospitals , Humans , Infant , Measles/complications , Measles/diagnosis , Measles/epidemiology , Oman/epidemiology , Pneumonia/etiology
2.
Sultan Qaboos Univ Med J ; 21(2): e302-e307, 2021 May.
Article in English | MEDLINE | ID: mdl-34221480

ABSTRACT

On 27 April 2020, the National Health Service England issued an emergency alert for a new condition owing to the observation of an increasing number of cases of a COVID-19-related hyperinflammatory syndrome termed multisystem inflammatory syndrome in children (MIS-C). Some of the presenting symptoms appeared similar to the Kawasaki disease and toxic shock syndrome. We report the cases of six children fitting the criteria of MIS-C, admitted to Royal Hospital and Sohar Hospital, Oman, between the months of June and July in 2020. Four of these patients required admission at the paediatric intensive care unit for inotropic support while two were admitted to the paediatric ward on suspicion of appendicitis. MIS-C has been reported in a small number of individuals below the age of 21 years with a median age of 9-10 years. Five of the current patients were aged less than the median age reported in the existing literature. All of the patients showed complete recovery with supportive management, intravenous immunoglobulin and steroids, with one patient requiring interleukin-6 inhibitor (tocilizumab).


Subject(s)
COVID-19/complications , Mucocutaneous Lymph Node Syndrome , Shock, Septic , Systemic Inflammatory Response Syndrome/virology , Child , Child, Preschool , Female , Humans , Infant , Male , Oman , Pandemics , SARS-CoV-2 , State Medicine
SELECTION OF CITATIONS
SEARCH DETAIL
...